Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Second Line Treatment”

1,285 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,285 results

Testing effectiveness (Phase 2)UnknownNCT03383237
What this trial is testing

Clinical Study of Apatinib as the Second-line Therapy in Malignant Melanoma

Who this might be right for
Malignant Melanoma
Henan Cancer Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT00519831
What this trial is testing

Ph II of Vinflunine and Cetuximab in Second Line Treatment of NSCLC

Who this might be right for
Lung Cancer
UNC Lineberger Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)UnknownNCT00303745
What this trial is testing

Irinotecan With or Without Capecitabine as Second-Line Therapy in Treating Older Patients With Progressive, Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Colorectal Cancer
Federation Francophone de Cancerologie Digestive 78
Testing effectiveness (Phase 2)Ended earlyNCT01133756
What this trial is testing

E7080 in Combination With Carboplatin + Gemcitabine Versus Carboplatin + Gemcitabine Alone as Second Line Therapy in Patients With Platinum-Sensitive Recurrent Ovarian Cancer by CA125

Who this might be right for
Ovarian Cancer
Eisai Inc. 7
Testing effectiveness (Phase 2)Study completedNCT00189410
What this trial is testing

Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic Tumours

Who this might be right for
Cancer of the Ovary Treated as 2nd Line TherapyMuellerian Mixed TumoursTumours of the Uterus+2 more
AGO Study Group 140
Testing effectiveness (Phase 2)Study completedNCT01777594
What this trial is testing

Study of G-202 (Mipsagargin) as Second-Line Therapy Following Sorafenib in Hepatocellular Carcinoma

Who this might be right for
Advanced Adult Hepatocellular Carcinoma
GenSpera, Inc. 25
Testing effectiveness (Phase 2)Study completedNCT00216099
What this trial is testing

Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Christopher Sweeney, MBBS 49
Testing effectiveness (Phase 2)Ended earlyNCT01402401
What this trial is testing

Phase II of AUY922 in Second-line Gastric Cancer in Combination With Trastuzumab in HER2 Positive Patients

Who this might be right for
Advanced Gastric Cancer
Novartis Pharmaceuticals 21
Testing effectiveness (Phase 2)Study completedNCT03110328
What this trial is testing

Study of Pembrolizumab in Metastatic Biliary Tract Cancer as Second-line Treatment After Failing to at Least One Cytotoxic Chemotherapy Regimen: Integration of Genomic Analysis to Identify Predictive Molecular Subtypes

Who this might be right for
Biliary Tract Cancer
Samsung Medical Center 33
Large-scale testing (Phase 3)Study completedNCT00805194
What this trial is testing

LUME-Lung 1: BIBF 1120 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 1,314
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07042919
What this trial is testing

Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaCirrhosisStage III Hepatocellular Carcinoma AJCC v8+1 more
Northwestern University 53
Large-scale testing (Phase 3)Study completedNCT01168973
What this trial is testing

Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy

Who this might be right for
Non-Small Cell Lung Cancer
Eli Lilly and Company 1,253
Testing effectiveness (Phase 2)Looking for participantsNCT06213311
What this trial is testing

Axicabtagene Ciloleucel and Glofitamab as Second-Line Therapy for Relapsed or Refractory Patients With Large B Cell Lymphoma

Who this might be right for
B Cell Lymphoma
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)Looking for participantsNCT04318730
What this trial is testing

Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma

Who this might be right for
Adrenocortical Carcinoma
West China Hospital 21
Post-approval studies (Phase 4)UnknownNCT05697614
What this trial is testing

The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children

Who this might be right for
Drug Resistant Epilepsy
Dr Cipto Mangunkusumo General Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT04327700
What this trial is testing

Study Of Intrabucally Administered Electromagnetic Fields and Regorafenib

Who this might be right for
Hepatocellular Carcinoma
Wake Forest University Health Sciences 2
Testing effectiveness (Phase 2)UnknownNCT03746652
What this trial is testing

Safety and Efficacy of Daratumumab in Combination With Ixazomib and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Hellenic Society of Hematology 50
Early research (Phase 1)UnknownNCT03276156
What this trial is testing

Apatinib in Combination With S-1 as Second-Line Treatment in Patients With Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Zhejiang Cancer Hospital 12
Testing effectiveness (Phase 2)Study completedNCT02095119
What this trial is testing

A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer

Who this might be right for
Uterine Cervical Cancer
National Institute of Cancerología 15
Testing effectiveness (Phase 2)Study completedNCT01832467
What this trial is testing

Cetuximab Rechallenge Study

Who this might be right for
Metastatic Colorectal Cancer
Chinese University of Hong Kong 17
Load More Results